Scienture Holdings, Inc.(SCNX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SCNX Scienture Holdings, Inc.

Trading 09-09 10:50:26 EDT

0.3792

+0.0155

+4.26%

High0.3850	Low0.3366	Vol7.95M
Open0.3399	D1 Closing0.3637	Amplitude13.31%
Mkt Cap15.57M	Tradable Cap12.86M	Total Shares41.06M
T/O2.88M	T/O Rate23.45%	Tradable Shares33.92M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SCNX","market":"US","secType":"STK","nameCN":"Scienture Holdings, Inc.","latestPrice":0.3792,"timestamp":1788965419645,"preClose":0.3637,"halted":0,"volume":7954797,"delay":0,"changeRate":0.0426175419301621,"floatShares":33915538,"shares":41064146,"eps":-2.03,"marketStatus":"Trading","change":0.0155,"latestTime":"09-09 10:50:26 EDT","open":0.3399,"high":0.385,"low":0.3366,"amount":2880011.50313058,"amplitude":0.133077,"askPrice":0.3803,"askSize":39,"bidPrice":0.3788,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-2.03,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788984000000},"marketStatusCode":2,"adr":0,"listingDate":1581570000000,"exchange":"NASDAQ","adjPreClose":0.3637,"preHourTrading":{"tag":"盘前","latestPrice":0.342,"preClose":0.3637,"latestTime":"09:28 EDT","volume":3697761,"amount":1393684.86366126,"timestamp":1788960529212,"change":-0.0217,"changeRate":-0.059665,"amplitude":0.387682},"postHourTrading":{"tag":"盘后","latestPrice":0.3641,"preClose":0.3637,"latestTime":"19:51 EDT","volume":12585,"amount":4580.4428,"timestamp":1788911467137,"change":0.0004,"changeRate":0.0011,"amplitude":0.005774},"volumeRatio":164.206235},"requestUrl":"/m/hq/s/SCNX/wiki","defaultTab":"wiki","newsList":[{"id":"2666653639","title":"SCIENTURE to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2666653639","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666653639?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:55","pubTimestamp":1788958500,"startTime":"0","endTime":"0","summary":"Management to Highlight Growing Commercial Momentum of Arbli and the Commercial Launch of REZENOPY COMMACK, NY, Sept.  09, 2026 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (“Scienture”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358685/0/en/scienture-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference-on-september-14-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666048372","title":"Scienture Holdings Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2666048372","media":"Reuters","labels":["conferences","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666048372?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:06","pubTimestamp":1788898011,"startTime":"0","endTime":"0","summary":"Scienture Holdings announces annual shareholder meetingScienture Holdings schedules its annual shareholder meeting for Oct. 28, 2026, to be held virtually.Shareholders will vote on electing five direc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL8dPcKt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883081","title":"Scienture Holdings CFO Eric Sherb Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883081","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883081?lang=en_us&edition=fundamental","pubTime":"2026-09-01 05:08","pubTimestamp":1788210481,"startTime":"0","endTime":"0","summary":"Scienture Holdings CFO Eric Sherb files initial beneficial ownership statementScienture Holdings CFO Eric Michael Sherb filed an initial Form 3 statement dated March 13, 2025.Disclaimer:This news brie","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL3ctdjX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659149431","title":"Scienture Holdings Q2 EPS $(0.07) Beats $(0.08) Estimate, Sales $343.639K Miss $1.964M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659149431","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659149431?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:23","pubTimestamp":1786710187,"startTime":"0","endTime":"0","summary":"Scienture Holdings (NASDAQ:SCNX) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.08) by 12.5 percent. This is a 85.42 percent increase over losses of $(0.48) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61206087/scienture-holdings-q2-eps-0-07-beats-0-08-estimate-sales-343-639k-miss-1-964m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659499201","title":"Scienture Q2 Revenue Surges on Rezenopy Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2659499201","media":"Reuters","labels":["productRelease","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659499201?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:17","pubTimestamp":1786709821,"startTime":"0","endTime":"0","summary":"Scienture Q2 revenue surges on REZENOPY launchOverviewUS specialty pharma firm's Q2 revenue rose sharply, driven by commercial launch of REZENOPYQ2 gross margin reached 97.7%, reflecting growing comme","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL1N44B0EN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","ETON","OMER","BK4167","BK4139","PTHS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659149341","title":"Scienture Holdings, Inc Q2 Operating Expenses USD 3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659149341","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659149341?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:08","pubTimestamp":1786709280,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nPLX1X3T7V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659346149","title":"Scienture Reports Q2 2026 Results with Approximately 510% Sequential Revenue Growth from Q1 2026 and Significant Improvement in Operating Performance","url":"https://stock-news.laohu8.com/highlight/detail?id=2659346149","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659346149?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:08","pubTimestamp":1786709280,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nTUA3D7CJS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659198688","title":"Scienture Holdings Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659198688","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659198688?lang=en_us&edition=fundamental","pubTime":"2026-08-14 05:17","pubTimestamp":1786655866,"startTime":"0","endTime":"0","summary":"Scienture Holdings Inc reports results for the quarter ended June 30 - Earnings SummaryScienture Holdings IncSCNX.OQreported a quarterly adjusted loss of 7 cents per share for the quarter ended June 3","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL8N44A29J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659620701","title":"Scienture Net Loss Narrows to $2.82 Million in Q2 FY26; Revenue Turns to $343,639","url":"https://stock-news.laohu8.com/highlight/detail?id=2659620701","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659620701?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:14","pubTimestamp":1786652098,"startTime":"0","endTime":"0","summary":"Scienture net loss narrows to $2.82 million in Q2 FY26; revenue turns to $343,639Scienture posted Q2 net loss of USD 2.82 million, narrowing 58% from a year earlier as revenue rose to USD 343,639.Gros","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL46bVDq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658999972","title":"Scienture Announces Commercial Launch and Fulfillment of Initial Purchase Orders of Rezenopy™, the Highest Dose FDA-Approved Naloxone Nasal Spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2658999972","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658999972?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:05","pubTimestamp":1786536300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUA5CRCVF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657664759","title":"Scienture Holdings Inc Expected to Post a Loss of 23 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657664759","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657664759?lang=en_us&edition=fundamental","pubTime":"2026-08-07 23:42","pubTimestamp":1786117325,"startTime":"0","endTime":"0","summary":"Scienture Holdings Inc <SCNX.OQ> expected to post a loss of23cents a share - Earnings PreviewScienture Holdings IncSCNX.OQSCNX.Ois expected to  report resultson August 10  for the period ending June 30 2026LSEG's mean analyst estimate for Scienture Holdings Inc is for a loss of 23 cents per share.The one available analyst rating on the shares is \"buy\".The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for Scienture Holdings Inc is $1.50, about 302.5% above its last closing price of $0.37This summary was machine generated August 7 at 15:42 GMT.  All figures in US dollars unless otherwise stated.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N4441XA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654014225","title":"When Will Scienture Holdings, Inc. (NASDAQ:SCNX) Become Profitable?","url":"https://stock-news.laohu8.com/highlight/detail?id=2654014225","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654014225?lang=en_us&edition=fundamental","pubTime":"2026-07-27 18:34","pubTimestamp":1785148458,"startTime":"0","endTime":"0","summary":"Scienture Holdings, Inc. ( NASDAQ:SCNX ) is possibly approaching a major achievement in its business, so we would like...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-scnx/scienture-holdings/news/when-will-scienture-holdings-inc-nasdaqscnx-become-profitabl","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-scnx/scienture-holdings/news/when-will-scienture-holdings-inc-nasdaqscnx-become-profitabl","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["QDTE","SCNX","ONEQ","TQQY","QYLG","TQQQ","QQQ","TECS","SQQQ","QQQY","NDX","QQQA","IYW","NQmain","MNQmain","QID","BK4167","GPIQ","QQQE","PSQ","JEPQ","NVIW.SI",".IXIC","QQQM","QQQJ","FTEC","QLD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650139854","title":"Analysts Are Bullish on Top Healthcare Stocks: Scienture Holdings (SCNX), Royalty Pharma (RPRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650139854","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650139854?lang=en_us&edition=fundamental","pubTime":"2026-07-10 23:10","pubTimestamp":1783696206,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Scienture Holdings (SCNX) and Royalty Pharma (RPRX) ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-scienture-holdings-scnx-royalty-pharma-rprx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-scienture-holdings-scnx-royalty-pharma-rprx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IHE","SCNX","BK4167","RPRX","PBE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650840861","title":"Scienture Holdings Stock Jumps Over 20% Pre-Market: Here's Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2650840861","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650840861?lang=en_us&edition=fundamental","pubTime":"2026-07-10 16:27","pubTimestamp":1783672020,"startTime":"0","endTime":"0","summary":"Scienture Holdings shares jumped 23.54% overnight after the company completed manufacturing inventory for the commercial launch of REZENOPY.","market":"hk","thumbnail":"https://cdn.benzinga.com/cdn-cgi/image/width=260,format=auto,quality=85/files/images/story/2026/07/10/Concept-Of-Stock-Market-And-Fintech--Blu.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/cdn-cgi/image/width=260,format=auto,quality=85/files/images/story/2026/07/10/Concept-Of-Stock-Market-And-Fintech--Blu.jpg"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/markets/equities/26/07/60377047/scienture-holdings-stock-jumps-over-20-pre-market-heres-why","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/07/60377047/scienture-holdings-stock-jumps-over-20-pre-market-heres-why","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BK4167","ODDS","BETZ","RSI","SCNX","BK4150"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650492734","title":"Scienture to begin shipments of Rezonopy to wholesalers","url":"https://stock-news.laohu8.com/highlight/detail?id=2650492734","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650492734?lang=en_us&edition=fundamental","pubTime":"2026-07-09 21:35","pubTimestamp":1783604110,"startTime":"0","endTime":"0","summary":"Scienture (SCNX) announced that it has completed manufacturing of commercial launch inventory and will begin shipments later this month of Rezonopy...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scienture-to-begin-shipments-of-rezonopy-to-wholesalers-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scienture-to-begin-shipments-of-rezonopy-to-wholesalers-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","EES","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650216559","title":"Scienture Holdings - to Begin July Shipments of Rezenopy Nasal Spray 10 Mg to U.S. Wholesalers","url":"https://stock-news.laohu8.com/highlight/detail?id=2650216559","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650216559?lang=en_us&edition=fundamental","pubTime":"2026-07-09 20:07","pubTimestamp":1783598874,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nFWN43B0XT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650921265","title":"SCIENTURE Announces Commercial Inventory Readiness and July Shipments of REZENOPY™ (naloxone hydrochloride) to Wholesalers","url":"https://stock-news.laohu8.com/highlight/detail?id=2650921265","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650921265?lang=en_us&edition=fundamental","pubTime":"2026-07-09 20:05","pubTimestamp":1783598700,"startTime":"0","endTime":"0","summary":"Commercial availability expected in August as the Company advances the rollout of the highest-dose FDA-approved naloxone hydrochloride nasal spray U.S. naloxone market totals ~$144 million in annual s","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/09/3324768/0/en/SCIENTURE-Announces-Commercial-Inventory-Readiness-and-July-Shipments-of-REZENOPY-naloxone-hydrochloride-to-Wholesalers.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX","CDC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644085938","title":"Scienture announces progress in commercialization of Arbli","url":"https://stock-news.laohu8.com/highlight/detail?id=2644085938","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644085938?lang=en_us&edition=fundamental","pubTime":"2026-06-18 20:30","pubTimestamp":1781785857,"startTime":"0","endTime":"0","summary":"Scienture (SCNX) announced significant progress in the commercialization of Arbli, including expanded payor coverage, broader pharmacy access, new ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scienture-announces-progress-in-commercialization-of-arbli-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scienture-announces-progress-in-commercialization-of-arbli-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642467683","title":"Scienture says large national health plan adds REZENOPY naloxone spray to formulary","url":"https://stock-news.laohu8.com/highlight/detail?id=2642467683","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642467683?lang=en_us&edition=fundamental","pubTime":"2026-06-09 20:05","pubTimestamp":1781006725,"startTime":"0","endTime":"0","summary":"Scienture secured formulary coverage for REZENOPY naloxone 10 mg nasal spray with a large national health plan.Coverage spans commercial insurance, Medicare supplemental plans, extending access to more than 100 million covered lives ahead of a mid-July launch.Prior GPO agreements provide access across more than 5,000 healthcare facilities, covering about 60% of the institutional GPO market.IQVIA data show the U.S. naloxone market at about $144 million in annual sales on 9,800,000 units.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nNDL5jRpv1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","IE00B64PRP62.GBP","SG9999014039.USD","LU2095319765.USD","LU2210149790.SGD","LU0130102774.USD","IQV","LU1201861249.SGD","LU0648000940.SGD","LU0130517989.USD","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","BK4167","IE00BN0W2W23.USD","LU1261432733.SGD","IE00B3QW5Z07.USD","LU0477156953.USD","LU0314104364.USD","BK4530","LU0882574055.USD","LU0130103400.USD","LU1201861165.SGD","NDAQ","IE00BKPKM429.USD","SG9999014005.SGD","BK4585","LU0980610538.SGD","IE00BN0W2T93.GBP","SG9999014013.SGD","LU1791710582.SGD","BK4588","LU0198837287.USD","LU0528227936.USD","LU0477156797.USD","LU1791710400.SGD","BK4112","LU0648001328.SGD","LU1989764748.USD","LU0130518102.USD","LU2210150020.SGD","BK4121","LU1989764664.SGD","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642676644","title":"SCIENTURE Secures Formulary Coverage for REZENOPY™ with a Large National Health Plan and Expands Commercial Team","url":"https://stock-news.laohu8.com/highlight/detail?id=2642676644","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642676644?lang=en_us&edition=fundamental","pubTime":"2026-06-09 20:05","pubTimestamp":1781006700,"startTime":"0","endTime":"0","summary":"Commercial Launch Planned for Mid-July; 5,000+ Healthcare Facilities Reached Through GPO Agreements, Covering ~60% of Institutional GPO Market U.S. naloxone market totals ~$144 million in annual sales","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/09/3308798/0/en/SCIENTURE-Secures-Formulary-Coverage-for-REZENOPY-with-a-Large-National-Health-Plan-and-Expands-Commercial-Team.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","VHT","NHLD","SCNX","TISI","BK4120"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.scientureholdings.com","stockEarnings":[{"period":"1week","weight":-0.009},{"period":"1month","weight":-0.0431},{"period":"3month","weight":0.0309},{"period":"6month","weight":-0.2876},{"period":"1year","weight":-0.5909},{"period":"ytd","weight":-0.2869}],"compareEarnings":[{"period":"1week","weight":0.0055},{"period":"1month","weight":-0.0094},{"period":"3month","weight":0.0559},{"period":"6month","weight":0.15},{"period":"1year","weight":0.1805},{"period":"ytd","weight":0.1232}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which offers price transparency, purchasing capabilities, and other value-added services; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Lutz, Florida.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.119636},{"month":2,"riseRate":0.333333,"avgChangeRate":0.150517},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.073293},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.066727},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.09045},{"month":6,"riseRate":0.857143,"avgChangeRate":0.461559},{"month":7,"riseRate":0.714286,"avgChangeRate":0.094869},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.141065},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.050222},{"month":10,"riseRate":0,"avgChangeRate":-0.160548},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.067192},{"month":12,"riseRate":0,"avgChangeRate":-0.185859}],"exchange":"NASDAQ","name":"Scienture Holdings, Inc.","nameEN":"Scienture Holdings, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Scienture Holdings, Inc.(SCNX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Scienture Holdings, Inc.(SCNX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Scienture Holdings, Inc.,SCNX,Scienture Holdings, Inc.股票,Scienture Holdings, Inc.股票老虎,Scienture Holdings, Inc.股票老虎国际,Scienture Holdings, Inc.行情,Scienture Holdings, Inc.股票行情,Scienture Holdings, Inc.股价,Scienture Holdings, Inc.股市,Scienture Holdings, Inc.股票价格,Scienture Holdings, Inc.股票交易,Scienture Holdings, Inc.股票购买,Scienture Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Scienture Holdings, Inc.(SCNX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Scienture Holdings, Inc.(SCNX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction